23/02/2023 |
Estimating the Effects of Daylight Saving Time Clock Changes on Cardiovascular Outcomes, Depressive Symptoms and Road Traffic Injuries in England |
23/02/2023 |
PREDICTion of GastroIntestinal malignancy in patients with IRON Deficiency (PREDICT-GI-IRON): a feasibility study |
21/02/2023 |
Trends in need-adjusted general practice consultation rates in England, 1995 - 2022 |
21/02/2023 |
How would the refinement of urgent cancer referral criteria, by the inclusion of a broader set of variables available in primary care health records, affect numbers of patients eligible for referral and their outcomes? |
20/02/2023 |
Epidemiology and health utilisation of patients treated with naldemedine; an observational retrospective cohort study |
17/02/2023 |
Second trimester loss: Estimating rates and understanding inequalities in loss - a retrospective cohort study in the CPRD database |
17/02/2023 |
Identifying prescriptions in electronic health care (EHR) studies: methods for development of standardised, reproducible drug codelists for patients with Chronic Obstructive Pulmonary Disease (COPD) |
17/02/2023 |
Pragmatic Randomised 104 Week Multicentre Trial to Evaluate the Comparative Effectiveness of dapagliflozin and Standard of Care in Type 2 Diabetes. The DECIDE Study. |
17/02/2023 |
Childbirth Acquired Perineal Trauma (Chapter) Study: Incidence of childbirth related perineal trauma (CRPT) and outcomes of women who experience CRPT |
17/02/2023 |
Familial Hypercholesterolaemia (FH) in the UK: Disparities in FH diagnosis and Intersectional Determinants of Health |
17/02/2023 |
Data availability for developing the EAMIT (East Anglian Malnutrition Identification Tool) Tool for earlier identification of malnutrition in the community: a feasibility study |
17/02/2023 |
Maternal and offspring outcomes associated with pre-pregnancy maternal multiple long-term conditions |
15/02/2023 |
Optimisation of care journeys for patients with diabetes and co-morbidiies in NHS England: identifying risks and opportunities for better outcomes |
15/02/2023 |
The effect of diabetes medications on chronic obstructive pulmonary disease exacerbations: a population-cohort study |
15/02/2023 |
Eligibility of patients with chronic obstructive pulmonary disease for triple therapy studies in routine clinical practice |
13/02/2023 |
Lipid-lowering therapy in young people with familial hypercholesterolaemia: A cohort study using primary and secondary care data to measure reductions in cholesterol, adherence, and safety |
13/02/2023 |
Factor Xa inhibitors associated major bleeding characterisation, burden and management in UK clinical setting: an observational study |
13/02/2023 |
Comparative effectiveness of sodium-glucose co-transporter-2 inhibitors (SGLT-2i), glucagon-like peptide-1 receptor agonists (GLP-1RA), or dipeptidyl peptidase-4 inhibitors (DPP-4i) vs. sulfonylureas (SU) in patients with type 2 diabetes |
13/02/2023 |
Characterization of the epidemiology, treatment patterns and burden of Pulmonary Hypertension Group 1 and 3 in the UK: a real-word evidence study. |
09/02/2023 |
To assess the comparative effectiveness and real-world utilization of novel oral anticoagulants in patients with nonvalvular atrial fibrillation in the United Kingdom |